| Product Code: ETC7756163 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Overview |
3.1 Jordan Country Macro Economic Indicators |
3.2 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume, 2021 & 2031F |
3.3 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market - Industry Life Cycle |
3.4 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market - Porter's Five Forces |
3.5 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic inflammatory demyelinating polyneuropathy (CIDP) in Jordan |
4.2.2 Growing awareness and diagnosis rates of CIDP among healthcare professionals and patients |
4.2.3 Advancements in treatment options and therapies for CIDP in the market |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities for CIDP treatment in Jordan |
4.3.2 High cost associated with CIDP medications and therapies |
4.3.3 Lack of reimbursement policies or insurance coverage for CIDP treatments |
5 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Trends |
6 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market, By Types |
6.1 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume, By Intravenous Immunoglobulin, 2021- 2031F |
6.1.4 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.1.5 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume, By Plasmapheresis, 2021- 2031F |
6.1.6 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume, By Physiotherapy, 2021- 2031F |
6.1.7 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume, By Electrodiagnostic Testing, 2021- 2031F |
6.2.3 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume, By Nerve Conduction, 2021- 2031F |
6.2.4 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume, By EMG, 2021- 2031F |
6.2.5 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume, By Spinal Fluid Analysis, 2021- 2031F |
6.2.6 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.3.3 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.4 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5.5 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenues & Volume, By Others, 2021- 2031F |
7 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Import-Export Trade Statistics |
7.1 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Export to Major Countries |
7.2 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Imports from Major Countries |
8 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis of CIDP in Jordan |
8.2 Number of neurologists specializing in CIDP per capita in the market |
8.3 Patient adherence rate to CIDP treatment regimens |
9 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market - Opportunity Assessment |
9.1 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market - Competitive Landscape |
10.1 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Revenue Share, By Companies, 2024 |
10.2 Jordan Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here